Calcibone

Quick links to important sections

Calcibone

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calcibone

Quick Facts

Property Description
Active Ingredients Calcium Carbonate / Citrate & Cholecalciferol (Vitamin D3)
Primary Form Oral (Tablets, Lozenges, Suspension)
Pharmacological Class Mineral and Vitamin D Supplement
General Purpose Nutritional support for bone maintenance
Type Combination Supplement

What Type of Supplement is Calcibone?

Calcibone is a brand name for a combination vitamin and mineral supplement, falling into the high-level Mineral and Vitamin D supplement pharmacological class. It is categorized as an oral nutritional agent, not a prescription drug for acute illness. Calcium and Vitamin D are essential for human health, particularly in maintaining skeletal integrity. This confirms the supplement's components are globally recognized as necessary nutrients.


What is Calcibone Made Of?

The supplement’s dual action is derived from its two core components: a form of Calcium and Cholecalciferol (Vitamin D3). The calcium component can vary by formulation, often being the concentrated Calcium Carbonate or Calcium Citrate. The Cholecalciferol is included to enhance the body's physiological capacity to absorb the calcium effectively. Calcibone is commonly available in various user-friendly oral dosage forms, such as chewable lozenges, coated tablets, or suspensions.


What is the General Purpose of Taking Calcibone?

The overall purpose of Calcibone is to ensure the body has sufficient, bioavailable levels of the primary nutrients required for strong bone health. Its typical use is to bridge dietary gaps or address increased nutritional demands across different life stages. Calcium and Vitamin D work synergistically to maintain bone health throughout life. This indicates the combination found in Calcibone is the evidence-based standard approach to supporting your bones. By providing this dual support, the supplement assists in general skeletal maintenance, muscle function, and nerve signaling.

Regulatory References

  1. WHO Essential Medicines List
  2. Essential Medicines List entry for Colecalciferol

What side effects are possible with Calcibone?

Possible Side Effects and Safety Information

Calcibone is a combination supplement containing Calcium Carbonate and Vitamin D3 (cholecalciferol), and it is generally well-tolerated when taken as directed. However, as with any supplement or medication, side effects may occur.

Common Side Effects

The most commonly reported side effects are gastrointestinal in nature and may include:

  • Constipation
  • Stomach upset or abdominal pain
  • Nausea and/or vomiting

Taking Calcibone with food or dividing the daily dose into smaller portions may help minimize these effects.


Serious Side Effects

Serious side effects are rare but typically result from hypercalcemia (high levels of calcium in the blood) or an allergic reaction. Contact a healthcare provider immediately if you experience signs of hypercalcemia or an allergic reaction:

Signs of Hypercalcemia Signs of Allergic Reaction
Increased thirst or urination Rash, hives, or itching
Confusion or mental changes Swelling of the face, tongue, or throat
Unusual weakness or fatigue Severe dizziness or trouble breathing

Warnings and Contraindications

Calcibone is not suitable for everyone. Do not take this supplement if you have:

  • Pre-existing high levels of calcium in your blood (hypercalcemia).
  • High levels of Vitamin D in your body (hypervitaminosis D).
  • A history of or current kidney stones.
  • Severe kidney impairment.

It is essential to inform your doctor or pharmacist about all other medications, supplements, or herbal products you are taking, as calcium and Vitamin D can interact with drugs such as certain antibiotics (e.g., tetracyclines, quinolones) and thyroid hormones (e.g., levothyroxine), potentially affecting their absorption or effectiveness.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Calcibone (Calcium and Vitamin D3) overdose is defined by the toxic condition of hypercalcaemia—an abnormally high level of calcium in the blood. This state results from acute or chronic overexposure to the components, particularly Vitamin D.


Documented Overdose Manifestations

Clinical signs of overdose documented in labeling include gastrointestinal disturbances such as nausea, vomiting, anorexia, and constipation. Systemic and neurological manifestations may involve weakness, apathy, confusion, and polyuria (frequent urination). Laboratory findings confirm the condition through elevated serum calcium levels.


Required Emergency Actions

If overdose is suspected, emergency medical care is required. The official guidance mandates the immediate and complete discontinuation of all intake of Calcibone and any other calcium or Vitamin D supplements. Management is defined as symptomatic and supportive treatment, involving procedures such as rehydration and, in severe cases, the use of diuretics or bisphosphonates to manage hypercalcaemia. Regulatory documentation confirms that no specific antidote is known.


Severe Outcomes and Monitoring

Severe overdose carries a risk of serious outcomes, including organ and vascular calcification, particularly nephrocalcinosis (kidney stone formation). Extreme hypercalcaemia may lead to cardiac arrhythmias. Severe cases require hospital monitoring of serum electrolytes and ECG to detect cardiac irregularity. Overdose must be strictly avoided during pregnancy due to documented risks to the developing fetus.

Therapeutic Uses of Calcibone

What Calcibone Treats: Main Uses and Benefits

Calcibone, as a supplement containing calcium and Vitamin D, is relevant in contexts marked by increased discomfort or tension related to mineral status. It is generally applied across domains where additional symptomatic support is needed, primarily to assist with symptomatic management. Getting enough of these nutrients may be part of symptomatic management related to bone density and is relevant for easing symptoms related to systemic imbalance.

Calcibone is commonly used to support patients experiencing symptomatic manifestations in conditions like osteoporosis and osteomalacia, and is applied in addressing symptom clusters that may become intense or disruptive, such as muscle weakness or cramps. It is also applied in high-demand physiological phases, including pregnancy and lactation, which are conditions marked by increased physiological stress.

This short-term symptomatic assistance is appropriate when symptoms interfere with daily functioning, supporting patients during difficult episodes and contributing to easing the overall symptom load associated with skeletal discomfort.


Quick Fact: Supports Management of Symptom Clusters

Regulatory References

  1. NIH MedlinePlus overview on Vitamin D and Calcium

Eligibility and Restrictions for Use

Who can and cannot use Calcibone?

Eligibility for Calcibone, which contains calcium and cholecalciferol (Vitamin D3), is determined by official regulatory documents based on existing levels of calcium and vitamin D, as well as a patient's overall health status.


Contraindicated Populations

Use of Calcibone is formally prohibited (contraindicated) for individuals with:

  • Hypercalcemia (high blood calcium levels).
  • Hypercalciuria (high urine calcium levels).
  • Hypervitaminosis D or Vitamin D toxicity (excessive vitamin D levels).
  • Known hypersensitivity or allergy to any component of the product.
  • Other conditions where calcium levels are already elevated, such as tissue calcification or a history of kidney stones.

Restricted Use and Special Considerations

Certain groups require special evaluation by a healthcare professional before use, as mandated by official labeling:

  • Pediatric Population: Safety and effectiveness are not established for use in children.
  • Existing Medical Conditions: Patients with kidney, liver, or heart problems require caution and may need a dose adjustment due to altered metabolism of calcium and vitamin D.
  • Specific Drug Interactions: Use is restricted or contraindicated when taken with certain medications, such as thyroid hormone (levothyroxine).
  • Pregnancy and Lactation: While used in special populations for proven deficiency, use during pregnancy and breastfeeding must be determined by a healthcare provider after weighing potential benefits and risks.

What should I know about interactions with other medicines?

The official regulatory profile for Calcibone (Calcium/Vitamin D3) is defined by pharmacokinetic (PK) and pharmacodynamic (PD) constraints. The most restrictive constraint is the documented risk of severe hypercalcaemia, which results in contraindicated combinations with other high-dose Vitamin D analogs (such as Calcitriol). A significant PD interaction also occurs with Thiazide diuretics, which reduce urinary calcium excretion and thereby increase the risk of hypercalcaemia. Due to this risk, strict monitoring is officially required when Calcibone is co-administered with Cardiac Glycosides (Digoxin).

The other major constraint is the PK reduction of oral absorption caused by the calcium ion. This results in mandatory administration separation rules for numerous medicines to ensure their therapeutic exposure. This requirement applies to Tetracycline and Quinolone antibiotics, which must be separated by several hours, and also to Levothyroxine (thyroid hormone replacement) and Bisphosphonates. Additionally, certain Anticonvulsants (e.g., Phenytoin, Carbamazepine) are documented to accelerate the metabolism/catabolism of the Vitamin D3 component (enzyme induction), potentially reducing its systemic effect. Dietarily, intake with high concentrations of oxalic acid or phytic acid is noted to inhibit the absorption of the calcium component itself. Official regulatory caution is also noted for patients with renal impairment due to the altered metabolic characteristics of Vitamin D.

Mechanism of Action

Intestinal Mineral Transport Upregulation

This core domain explains the molecular action of Cholecalciferol ( Vitamin D3), which acts as a nuclear receptor agonist on the Vitamin D Receptor ( VDR). This interaction drives gene transcription, resulting in the increased synthesis and expression of specialized transport proteins, notably TRPV6 ion channels and Calbindin proteins, in the intestinal lining. This genomic mechanism modifies the cellular machinery, leading to a quantifiable increase in the net active transfer of Ca^2+ from the gut lumen into the bloodstream.


Substrate Synergy and Systemic Modulation

The mechanism relies on a functional synergy where the Ca^2+ component provides the mineral substrate via passive ion exchange, while the Vitamin D3 mechanism provides the increased transport capacity. The resulting robust delivery of calcium ions fuels the skeletal mineralization pathway, providing the substrate for hydroxyapatite formation within the bone matrix. Furthermore, the elevation of systemic Ca^2+ levels triggers an indirect feedback loop that modulates the parathyroid glands, leading to the suppression of Parathyroid Hormone ( PTH) secretion. This regulatory mechanism contributes to the stabilization of mineral homeostasis by limiting PTH-driven osteoclast signaling.

Dosage and Administration Information

Calcibone, a combination of Calcium and Vitamin D3, is formulated for oral administration. This mineral and vitamin combination is available in several forms, including film-coated tablets, which must be swallowed whole, and chewable tablets, which must be chewed or sucked completely before being swallowed to ensure the proper release of active ingredients. The use of any liquid or suspension form also follows the oral route.

The dosing schedule involves the calculation of the total daily intake. Standard adult regimens typically provide between 600 mg and 1200 mg of elemental calcium daily, usually taken in divided doses (e.g., one tablet twice daily) to optimize absorption. The product labeling specifies a maximum daily dose that must not be exceeded, which requires accounting for all dietary and supplemental sources of both Calcium and Vitamin D.

Regarding administration timing, the product may be taken with food or with a full glass of water for best absorption, though some labeling permits intake without food. A crucial procedural condition mandates that the dose must be separated by 2 to 4 hours from certain other oral medications, such as specific antibiotics or thyroid hormones, to prevent interference with absorption. Use of Calcibone is commonly established as long-term therapy and requires periodic monitoring of serum and urinary calcium levels, with dose adjustment or interruption necessary if high levels of calcium excretion are detected. Use in specific populations like pediatric patients (under 12) or those with severe renal impairment is generally not recommended.

Recent Clinical Evidence

Research evidence / Overview of Studies for Calcibone

This overview summarizes the types of research, key study populations, and general findings reported in scientific literature and regulatory documents regarding the combined use of calcium and Vitamin D, which is contained in Calcibone. It is designed to explain what the evidence shows without offering medical advice.


Evidence for Use in Osteoporosis and Fracture Prevention

Research has extensively explored the role of calcium and Vitamin D supplementation in research contexts related to bone health, particularly in clinical contexts like osteoporosis and research exploring the rate of fracture incidents. The primary research used to evaluate this combination consists of Randomized Controlled Trials (RCTs) and large-scale Meta-analyses.

These studies were conducted across diverse populations, focusing primarily on older adults and postmenopausal women. Researchers used these trials to examine the rate of new hip and non-hip fractures and to monitor changes in Bone Mineral Density (BMD). Reported findings were inconsistent across the body of research. Some trials described patterns related to the rate of fracture incidents in specific study groups, such as those with confirmed nutrient deficiencies or who were institutionalized. Conversely, research exploring healthy, community-dwelling populations often found that the data show limited patterns related to fracture prevention. Overall, evidence contributes to understanding symptom patterns related to systemic imbalance, but the impact may differ significantly based on an individual's existing status.


Evidence for Correction of Mineral Deficiency and Bone Maintenance

Research has also explored the use of the Calcium and Vitamin D combination in research contexts related to conditions where symptoms may vary in intensity due to systemic nutritional imbalance, such as low vitamin D levels. The research in this area relies on clinical trials focusing on biochemical changes and Well-Established Use (WEU) literature.

Studies primarily monitored how these supplements were monitored in relation to the body's mineral status. Findings indicate that the supplement was associated with the normalization of these essential nutrient levels in some studies, and the data show patterns related to the stabilization of certain metabolic markers. Scientific literature and regulatory bodies describe how the correction of these specific laboratory deficiencies is addressed. Studies monitored outcomes related to physical discomfort, such as muscle cramps, in the context where these symptoms are associated with a diagnosed systemic deficiency.


What Remains Uncertain and Research Gaps

The research evidence, while extensive, is not without limitations. Certainty remains low regarding the effect on fracture rates in adults who are not deficient in these nutrients, meaning the benefits are less established in these groups. Furthermore, the evidence quality varies across studies due to differences in design and participant characteristics. Key limitations include that the results apply only to the populations studied, and extrapolating these findings broadly can be challenging. Comparative evidence is lacking in terms of how this combination directly compares to every other form of calcium and vitamin D.

Key Studies & References

  1. Overview of Vitamin D and Calcium (Patient Instructions)
  2. Cochrane Review on Vitamin D and Calcium Supplementation for Fracture Prevention (Representative Meta-Analysis)

Frequently Asked Questions (FAQ)

Common questions about Calcibone (FAQ)


Q: Are there any long-term health concerns associated with using Calcibone?

A: Regulatory documents state that Calcibone is commonly intended for sustained or long-term therapy. Due to this continuous use, official guidance mandates the periodic monitoring of calcium levels in the blood and urine. This monitoring is required to help manage the risk of developing hypercalcaemia, which is a potentially serious condition where calcium levels in the blood become too high.

Q: Does Calcibone need to be taken at a specific time of day?

A: Official product information indicates that the supplement may be taken with food or with a full glass of water to facilitate the administration of the ingredients. However, official labels do not specify or mandate a particular time of day (such as morning or evening) for administration.

Q: What is the definition of a 'contraindication' for Calcibone?

A: A contraindication is an official regulatory term that describes a condition or circumstance that makes the use of a specific supplement or medicine strictly prohibited. This is because the known risks or potential for harm in that circumstance is deemed to outweigh any possible therapeutic benefit.

Q: Do studies show Calcibone helps with long-term condition management?

A: Clinical studies and official guidance describe the product's function in the long-term management of nutritional status. The supplement helps by correcting specific mineral deficiencies and contributing to the stabilization of metabolic markers related to bone health.

Q: Can Calcibone affect blood test results?

A: Yes, official guidance indicates that use of Calcibone requires periodic monitoring because it is monitored in relation to specific blood parameters. This monitoring typically involves measuring serum and urinary calcium levels to ensure they remain within an acceptable range.

Q: Are there different strengths or forms of Calcibone available?

A: According to the official product information, Calcibone is often available in different strengths, containing varying amounts of elemental calcium. It is also available in multiple forms, which may include film-coated tablets, chewable lozenges, and oral suspensions.

Q: What does 'mechanism of action' mean for Calcibone in simple terms?

A: The mechanism of action describes how the supplement works inside the body. For Calcibone, the Vitamin D component functions by increasing the body’s capacity to absorb calcium from the gut, while the calcium component provides the necessary mineral substrate for strong bone maintenance.

Q: How quickly should I expect Calcibone to start having an effect?

A: Regulatory documents describe the time it takes for the components to be absorbed and reach peak concentration in the blood. However, the long-term clinical benefits related to skeletal health are discussed in the context of sustained, long-term therapy.

Q: Is it common for people to experience changes in appetite while taking Calcibone?

A: Changes in appetite are not commonly listed as a direct side effect in official documents. However, the most frequently reported adverse effects are gastrointestinal, including nausea, vomiting, and stomach upset.

Q: Are there known issues when taking Calcibone with common vitamins or supplements?

A: Official regulatory documents caution against taking any other vitamin or mineral supplements that contain calcium or Vitamin D without professional guidance. This is due to the increased risk of elevated calcium levels in the blood (hypercalcaemia).

Q: What happens if I forget to take Calcibone for a day?

A: Regulatory guidance states the administration rule for a missed dose is to take it as soon as it is remembered, unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped. The guidance specifies that a double dose should not be taken.

Q: Is Calcibone known to cause any issues with sleep?

A: Sleep disturbance is not commonly listed as a general side effect. However, confusion or mental changes are documented signs of the serious, rare condition of hypercalcaemia (high calcium levels), which may require medical attention if observed.

Q: Does Calcibone have a generic version available?

A: While Calcibone is a specific brand name, its active components—Calcium and Vitamin D3—are basic nutrients. These ingredients are available in numerous generic or equivalent products, as documented in regulatory lists like DailyMed.

Q: How is the safety of Calcibone monitored after it has been released?

A: Post-release safety is officially monitored through pharmacovigilance programs run by regulatory bodies. These programs rely on healthcare professionals and consumers reporting any new or serious adverse events to regulatory bodies like the FDA or EMA.

Q: Can drinking coffee affect how Calcibone works?

A: Official regulatory documents generally caution that the absorption of the calcium component can be inhibited by substances such as oxalic acid or phytic acid found in certain foods. The product labeling notes that absorption can be altered by various dietary components.

Q: What is the research background for the development of Calcibone?

A: The research background is based on extensive clinical data, primarily Randomized Controlled Trials (RCTs) and Meta-analyses. These studies were conducted to evaluate the combined use of calcium and Vitamin D in clinical contexts like osteoporosis and fracture prevention.

Q: Does Calcibone interact with pain relief medicines that are available over-the-counter?

A: Official guidance requires informing a healthcare provider about all nonprescription medications, including pain relievers, due to the potential for the calcium component to interfere with the absorption of other medicines.

Q: Can Calcibone affect how I feel emotionally or my mood?

A: While not a common mood side effect, the serious condition of high calcium levels (hypercalcaemia) is officially documented to cause signs such as confusion or mental changes. Confusion or mental changes are neurological signs associated with this serious condition.

Q: What is the purpose of the black box warning (if any) on Calcibone?

A: A Black Box Warning (or Boxed Warning) is the highest safety alert assigned by the FDA to call attention to major risks that may lead to death or serious injury. Supplements like Calcibone, which are non-prescription, are generally not subject to these serious warnings.

Q: Do health regulators monitor Calcibone differently in various countries?

A: All major global health regulators, such as the FDA, EMA, and Health Canada, are officially mandated to monitor the safety and effectiveness of authorized supplements and medications. While specific practices vary, the core regulatory requirement for continuous post-market surveillance remains the same across these bodies.

Q: Does Calcibone have a risk of dependence or addiction?

A: Calcibone is officially classified as a mineral and vitamin supplement. Official regulatory bodies typically limit the assessment of abuse potential and dependence to substances with central nervous system (CNS) activity, which does not apply to this type of supplement.

Q: Are there any specific lifestyle changes mentioned in connection with Calcibone use?

A: Official guidance emphasizes that the supplement is typically part of an overall approach to health. This may include dietary adjustments to ensure the total daily calcium intake (from food and supplements) is not exceeded, and it is generally prescribed in the context of periodic medical monitoring.

Q: What does the term 'off-label use' mean for a drug like Calcibone?

A: The term off-label use is a regulatory designation that describes when a medicine is prescribed or used for a purpose or in a manner that is not specifically authorized or approved by the official health regulatory body.

Q: Are there any known issues with taking Calcibone alongside alcohol?

A: Regulatory information for calcium carbonate often notes a moderate interaction risk with heavy or chronic alcohol use because chronic alcohol consumption is known to affect bone mineral density.

Q: What is the significance of the research phase names (Phase 1, 2, 3) for Calcibone?

A: The different phases (Phase 1, 2, and 3) represent the staged process of clinical research used to gather evidence on a product. These phases assess a product’s safety, optimal dosage, and effectiveness before it can receive official regulatory authorization.

Q: Is Calcibone a controlled substance?

A: No, Calcibone is classified as a mineral and vitamin supplement. It is not listed as a scheduled drug under official controlled substances regulations and does not possess characteristics that would designate it as a controlled substance.

Q: What is the most common reason people stop taking Calcibone?

A: Data from clinical trials often indicate that the most common reasons for patient discontinuation are related to the frequently reported, minor gastrointestinal side effects. These typically include issues such as constipation or stomach upset.

How should Calcibone be stored and disposed of?

How to Store and Dispose of Calcibone

Official regulatory guidelines for this calcium and Vitamin D supplement define specific requirements to ensure product stability and safety.

Storage and Handling Requirement Regulatory Statement
Temperature & Environment Store at room temperature (e.g., between 15°C and 25°C) and do not freeze. Protect the product from light and moisture and avoid excess heat.
Container Rule Keep the medication in its original container and ensure the lid is tightly closed at all times.
Child Safety The product must be stored out of the sight and reach of children to prevent accidental ingestion.

Do not use the supplement past the labeled expiration date. Disposal instructions require that unused or expired product not be thrown into household trash or wastewater. Instead, dispose of the product according to official local regulations or a community medicine take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Calcibone found in:

A-Z Index: